The present invention relates to substituted pyrimidinyl- and pyridinylpyrrolopyridinone compounds which modulate the activity of protein kinases and are therefore useful in treating diseases caused by dysregulated protein kinase activity, in particular RET family kinases. The present invention also provides methods for preparing these compounds, pharmaceutical compositions comprising these compounds, and methods of treating diseases utilizing pharmaceutical compositions containing these compounds.
本发明涉及取代的
嘧啶基和
吡啶基
吡咯吡啶酮化合物,其调节蛋白激酶活性,因此在治疗由失调的蛋白激酶活性引起的疾病中特别有用,特别是RET家族激酶。本发明还提供了制备这些化合物的方法、包含这些化合物的制药组合物以及利用含有这些化合物的制药组合物治疗疾病的方法。